- Report
- January 2025
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- September 2024
- 168 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2024
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 157 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- November 2024
- 177 Pages
Global
From €3969EUR$4,175USD£3,334GBP
- Report
- September 2022
- 144 Pages
Global
From €5704EUR$6,000USD£4,792GBP
- Report
- June 2023
- 211 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- November 2020
- 40 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2022
- 155 Pages
Global
From €4230EUR$4,450USD£3,554GBP
The In Vitro Diagnostics (IVD) Contract Manufacturing market is a specialized sector of the medical device industry that focuses on the production of diagnostic tests and related products. It involves the outsourcing of production activities to a third-party manufacturer, allowing companies to focus on their core competencies. Contract manufacturers provide a range of services, including product design, development, and manufacturing, as well as regulatory and quality assurance support. This allows companies to reduce costs, increase efficiency, and improve product quality.
The IVD Contract Manufacturing market is highly competitive, with a number of established players offering a wide range of services. Companies in the market include AbbVie Contract Manufacturing, Becton Dickinson, Merck KGaA, and Thermo Fisher Scientific. Show Less Read more
